Generix Group announced the appointment of Aïda Collette-Sène as President and Chairman of the Board. She succeeds Jean-Charles Deconninck. This handover takes place in the context of the change in the Group's shareholding structure and its delisting from the stock market as a result of the simplified takeover bid initiated by Montefiore Investment, Pléiade Investissement and Generix Group's management, through New Gen Holding.

This appointment is effective since September 1, 2022.